PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Sep-2022 Studies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid Depression Businesswire
08-Sep-2022 Sensorion to participate in the Inner Ear Biology Workshop in September 2022 Businesswire
08-Sep-2022 Genexine’s First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervical Cancer Businesswire
08-Sep-2022 BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Businesswire
08-Sep-2022 Exelixis Announces Detailed Results from Phase 3 COSMIC-313 Pivotal Trial in Patients with Previously Untreated Advanced Kidney Cancer at ESMO 2022 Businesswire
08-Sep-2022 Seagen to Highlight Research in Urothelial and Colorectal Cancers at 2022 European Society for Medical Oncology (ESMO) Congress Businesswire
07-Sep-2022 Ian Read devient président du conseil d'administration d'Areteia Therapeutics Businesswire
07-Sep-2022 SQZ Biotechnologies to Present at Upcoming Investor Conferences Businesswire
07-Sep-2022 NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer Businesswire
07-Sep-2022 Adicet Bio to Present at Upcoming Investor Conferences Businesswire
07-Sep-2022 Devonian Announces the Issuance of Units in Settlement of Interests Owed to Debenture Holders Businesswire
07-Sep-2022 Resumen: Ian Read, nombrado presidente del consejo de administración de Areteia Therapeutics Businesswire
07-Sep-2022 Harris Williams Advises Jordi Labs on its Sale to RQM+ Businesswire
07-Sep-2022 Dr. Reddy's Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity Businesswire
07-Sep-2022 Outlook on the Continuous Bioprocessing Global Market to 2027 - by Product, End-user, Application and Region - ResearchAndMarkets.com Businesswire
07-Sep-2022 Riassunto: Ian Read nominato Presidente del CdA di Areteia Therapeutics Businesswire
07-Sep-2022 Samenvatting: Ian Read benoemd tot voorzitter van de raad van bestuur van Areteia Therapeutics Businesswire
07-Sep-2022 Ian Read wird Vorstandsvorsitzender von Areteia Therapeutics Businesswire
07-Sep-2022 Neomorph, Inc. Announces Appointment of Chief Financial Officer Businesswire
07-Sep-2022 Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 Businesswire